CPHI Pharma Awards 2025 recognized innovations in bio/pharmaceutical development, emphasizing sustainability, drug delivery, ...

Pharmaceutical Technology® spoke with Dr. Weite Oldenziel, CEO of Ofichem, before CPHI Frankfurt 2025 to get his perspective ...

State-of-the-art AI programs can support the development of drugs by predicting how proteins interact with small molecules.

Picking a date for a press conference in Puerto Rico in the middle of hurricane season can be risky business. | Eli Lilly has ...

VAI means objectionable conditions or practices were found, but the regulator is not prepared to take or recommend any administrative or regulatory action.

Cambrex will invest $120M to expand U.S. drug manufacturing, boosting API capacity at its Iowa site and adding jobs amid ...

Next year will be the twentieth anniversary of a successful lawsuit against the state, “Myers v. Alaska Psychiatric Institute ...

The US drug regulator has turned its lens on Hetero, issuing back-to-back Form 483s to its API Unit 9 and warehouse in ...

India on Monday advanced an anti-dumping investigation into imports from China and Thailand of Ethambutol Hydrochloride, an ...

NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

Hyderabad: Granules India Limited, a pharmaceutical manufacturing company, has announced that it has received an ...

South Africa has become the first African country – and our medicines regulator the third worldwide – to register the ...